Page results
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
Oropharyngeal cancer is a type of cancer that affects the part of the throat at the back of the mouth.
-
Evidence shows that in selected cases open fetal surgery to close the spina bifida defect improves baby outcomes compared to surgery after birth.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
-
Patient information for patients who are having a bone marrow biopsy.
-
This page is intended for women with a cyst or abscess of the Bartholin’s gland. It provides information on the condition and the treatment options available in our hospital.
-
This page has been written by the Paediatric and Adolescent Gynaecology team for parents and carers of children with vulvovaginitis.
File results
-
FOI/2022/0757 - Oncology services - staff/ patients
-
FOI/2022/0724 - Radiology enquiry - brain imaging, prostate, breast, Liver, Gynaecological scans within MRI
-
FOI/2022/0742 - Allegations of sexual misconduct in NHS Trusts
-
FOI/2022/0745 - Elective/ emergency C-sections and number of still births/ neonatal deaths
-
FOI/2022/0748 - Services closed at Trust due to staffing issues
-
FOI/2022/0751 - Pharmacy solution to remotely monitor fridge temperature
-
FOI/2022/0754 - Respiratory devices
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0768 - Patients treated for Haemophila A